Waldron Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.71M Sell
12,994
-57
-0.4% -$19.5K 0.16% 62
2026
Q1
$4.59M Buy
13,051
+142
+1% +$50.6K 0.18% 62
2025
Q4
$4.23M Buy
12,909
+49
+0.4% +$15.5K 0.17% 62
2025
Q3
$3.63M Sell
12,860
-129
-1% -$37.4K 0.15% 66
2025
Q2
$3.63M Sell
12,989
-52
-0.4% -$14.7K 0.16% 69
2025
Q1
$4.06M Sell
13,041
-3,969
-23% -$1.17M 0.19% 64
2024
Q4
$4.43M Sell
17,010
-333
-2% -$98.8K 0.18% 70
2024
Q3
$5.59M Buy
17,343
+95
+0.6% +$31.1K 0.23% 59
2024
Q2
$5.39M Sell
17,248
-147
-0.8% -$43.2K 0.24% 57
2024
Q1
$4.95M Buy
17,395
+7
+0% +$2.05K 0.22% 58
2023
Q4
$5.01M Sell
17,388
-137
-0.8% -$37.3K 0.24% 54
2023
Q3
$4.71M Buy
17,525
+8
+0% +$2K 0.24% 54
2023
Q2
$3.89M Buy
17,517
+184
+1% +$42.7K 0.19% 66
2023
Q1
$4.19M Sell
17,333
-600
-3% -$147K 0.2% 66
2022
Q4
$4.04M Hold
17,933
0.25% 60
2022
Q3
$4.04M Sell
17,933
-157
-0.9% -$38.1K 0.25% 60
2022
Q2
$4.4M Buy
18,090
+385
+2% +$94.3K 0.25% 60
2022
Q1
$4.28M Sell
17,705
-87
-0.5% -$20K 0.22% 71
2021
Q4
$4M Buy
17,792
+159
+0.9% +$33.6K 0.2% 73
2021
Q3
$3.75M Buy
17,633
+1,579
+10% +$363K 0.22% 68
2021
Q2
$3.91M Buy
16,054
+303
+2% +$74.5K 0.25% 59
2021
Q1
$3.92M Sell
15,751
-42
-0.3% -$10K 0.27% 56
2020
Q4
$3.63M Sell
15,793
-46
-0.3% -$10.6K 0.27% 55
2020
Q3
$4.03M Buy
15,839
+486
+3% +$120K 0.34% 47
2020
Q2
$3.62M Sell
15,353
-5,252
-25% -$1.2M 0.32% 44
2020
Q1
$4.18M Sell
20,605
-327
-2% -$71.4K 0.45% 44
2019
Q4
$5.05M Buy
20,932
+39
+0.2% +$8.6K 0.45% 36
2019
Q3
$4.04M Buy
20,893
+19,445
+1,343% +$3.73M 0.41% 43
2019
Q2
$266K Sell
1,448
-367
-20% -$65.7K 0.03% 202
2019
Q1
$344K Sell
1,815
-283
-13% -$54K 0.04% 174
2018
Q4
$408K Buy
+2,098
New +$409K 0.06% 140
2017
Q2
Sell
-2,742
Closed -$444K 141
2017
Q1
$444K Buy
+2,742
New +$456K 0.11% 115
2016
Q3
Sell
-1,574
Closed -$239K 150
2016
Q2
$239K Buy
+1,574
New +$245K 0.09% 132

Other funds holding AMGN

Waldron Private Wealth's AMGN Position: Q2 2026 in Review

Waldron Private Wealth reduced its Amgen (AMGN) stake by 0.44% in Q2 2026, selling an estimated $19.5K and leaving 12,994 shares worth $4.71M. The position accounts for 0.16% of the portfolio, ranked #62.

Waldron Private Wealth first reported a position in AMGN in Q2 2016 and has held it in 33 quarters since. The position peaked at $5.59M in Q3 2024. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Waldron Private Wealth held 12,994 shares of Amgen worth $4.71M as of Q2 2026.
  • Waldron Private Wealth sold 57 Amgen shares in Q2 2026, an estimated $19.5K.
  • Amgen made up 0.16% of Waldron Private Wealth's portfolio in Q2 2026, its #62 holding.
  • Waldron Private Wealth first reported a position in Amgen in Q2 2016 and has held it in 33 quarters since.
  • Waldron Private Wealth's Amgen position peaked at $5.59M in Q3 2024.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.